Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer.
McKay RR, Zukotynski KA, Werner L, Voznesensky O, Wu JS, Smith SE, Jiang Z, Melnick K, Yuan X, Kantoff PW, Montgomery B, Balk SP, Taplin ME. McKay RR, et al. Prostate Cancer Prostatic Dis. 2014 Dec;17(4):325-31. doi: 10.1038/pcan.2014.28. Epub 2014 Aug 5. Prostate Cancer Prostatic Dis. 2014. PMID: 25091040 Free PMC article. Clinical Trial.
The role of miRNAs in prostate cancer.
Sun T, McKay R, Lee GS, Kantoff P. Sun T, et al. Eur Urol. 2015 Oct;68(4):589-90. doi: 10.1016/j.eururo.2014.12.037. Epub 2015 Jan 7. Eur Urol. 2015. PMID: 25577717 No abstract available.
Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease.
Sarkar RR, Patel SH, Parsons JK, Deka R, Kumar A, Einck JP, Mundt AJ, Kader AK, Kane CJ, Riviere P, McKay R, Murphy JD, Rose BS. Sarkar RR, et al. Among authors: mckay r. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):689-695. doi: 10.1038/s41391-020-0241-3. Epub 2020 Jun 8. Prostate Cancer Prostatic Dis. 2020. PMID: 32513967 Free PMC article.
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
McGregor BA, Campbell MT, Xie W, Farah S, Bilen MA, Schmidt AL, Sonpavde GP, Kilbridge KL, Choudhury AD, Mortazavi A, Shah AY, Venkatesan AM, Bubley GJ, Siefker-Radtke AO, McKay RR, Choueiri TK. McGregor BA, et al. Among authors: mckay rr. Cancer. 2021 Mar 15;127(6):840-849. doi: 10.1002/cncr.33328. Epub 2020 Nov 20. Cancer. 2021. PMID: 33216356 Free article. Clinical Trial.
292 results